Eli Casdin is a Board Observer at Verana Health. Eli has also served as CEO of EQRx, a healthcare company. Prior to that, they were the CEO of New York Genome Center, Tenaya Therapeutics, PACT Pharma, and Genomatica. Eli has also served on the board of directors of Maze Therapeutics, Prominex Inc., and Columbia University School of General Studies. Eli is the founder of Casdin Capital, LLC.
Eli Casdin graduated from Riverdale Country School and then went on to study finance and accounting at Columbia University in the City of New York. Eli then earned their MBA from Columbia Business School.
Links